Journal of Hematology and Oncology Research

Shuaiying Cui, PhD, University of Science and Technology of China
Editorial Board

Shuaiying Cui PhD

PhD, University of Science and Technology of China · China

Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601

Research interests

  • Hematologic Disorders
  • Sickle Cell Disease
  • Beta-Thalassemia
  • Acute Myeloid Leukemia
  • Blood Cancer

Biography

Dr. Cui's research has focused on the development of novel agents that can elicit developmental stage-specific gene silencing or reprogramming in hematopoietic stem cells and progenitors through a series of epigenetic chromatin modifications by nucleosome remodeling, histone deacetylation and demethylation. Such agents can be applied to the treatment of the patients with hematologic disorders such as sickle cell disease and beta-thalassemia, as well as acute myeloid leukemia (Blood cancer), which arise from congenital defects in genome. The findings from these preclinical studies could also help to establish therapeutic indications in other hematological malignancies.

Considering JHOR for your work?

This journal is guided by Shuaiying Cui (PhD, University of Science and Technology of China) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu